drugset / Trial / NCT02874690

Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD

NCT02874690

Phase 0 Completed 40 enrolled Children's Hospital Medical Center, Cincinnati
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The overall goal of this research is to use neurophysiological measures to profile strengths and deficits for Attention Deficit Hyperactivity Disorder co-morbidity in Autism Spectrum Disorder to clarify diagnosis and to predict treatment response.

Timeline

Start
2016-02-19
Primary completion
2017-08-03
Completion
2017-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 0.3 mg/kg